OverviewSuggest Edit

TherapeuticsMD operates as a women's health care product company. The Company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, and natural menopause relief products under the vitaMedMD brand, as well as generic formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. TherapeuticsMD creates products to address the unique changes and challenges women experience through every stage of their lives.
TypePublic
Founded2008
HQBoca Raton, US
Websitetherapeuticsmd.com
Employee Ratings3.1

Latest Updates

Employees (est.) (Dec 2019)348(+45%)
Job Openings11
Revenue (FY, 2019)$49.6 M(+209%)
Share Price (May 2020)$1.1 (-3%)

Key People/Management at TherapeuticsMD

Tommy G. Thompson

Tommy G. Thompson

Chairman of the Board
Robert G. Finizio

Robert G. Finizio

Chief Executive Officer, Co-Founder, and Director
Dan Cartwright

Dan Cartwright

Chief Financial Officer
John Milligan

John Milligan

President
Dawn Halkuff

Dawn Halkuff

Chief Commercial Officer
Brian Bernick

Brian Bernick

Co-Founder
Show more

TherapeuticsMD Office Locations

TherapeuticsMD has an office in Boca Raton
Boca Raton, US (HQ)
951 Yamato Rd #220
Show all (1)

TherapeuticsMD Financials and Metrics

TherapeuticsMD Revenue

Embed Graph
View revenue for all periods
TherapeuticsMD's revenue was reported to be $49.65 m in FY, 2019
USD

Revenue (Q1, 2020)

12.3m

Gross profit (Q1, 2020)

9.5m

Gross profit margin (Q1, 2020), %

77.8%

Net income (Q1, 2020)

(56.8m)

EBIT (Q1, 2020)

(50.9m)

Market capitalization (29-May-2020)

307.0m

Closing stock price (29-May-2020)

1.1

Cash (31-Mar-2020)

170.1m

EV

389.1m
TherapeuticsMD's current market capitalization is $307 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

2.1m3.8m8.8m15.0m20.1m19.4m16.8m16.1m49.6m

Revenue growth, %

71%34%(4%)

Cost of goods sold

947.1k1.3m2.0m3.7m4.5m4.2m2.6m2.7m6.3m

Gross profit

1.1m2.5m6.8m11.4m15.6m15.2m14.1m13.4m43.3m
Quarterly
USDY, 2020

EV/EBIT

-7.6 x

EV/CFO

-9.9 x

Financial Leverage

-5.9 x
Show all financial metrics

TherapeuticsMD Online and Social Media Presence

Embed Graph

TherapeuticsMD News and Updates

Global Vasomotor Symptoms Market (2017 to 2030) - Featuring TherapeuticsMD, Astellas Pharma & Mitsubishi Tanabe Pharma Among Others

DUBLIN, March 23, 2020 /PRNewswire/ -- The "Vasomotor symptoms (Hot flashes/Night sweats) - Market Insights, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding of the Vasomotor...

TherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health Products

SAN FRANCISCO, Jan. 7, 2020 /PRNewswire/ -- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, and PlushCare, a virtual health platform that enables patients to book a virtual doctor's appointment to get treatment, today announced that TherapeuticsMD's women's...

Knight and TherapeuticsMD Announce Filing of New Drug Submission for Bijuva® in Canada

MONTREAL and BOCA RATON, Fla., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”) and TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD”) announced today that Knight's New Drug Submission (NDS) for Bijuva® has been accepted for review by Health Canada. Bijuva is a …

TherapeuticsMD Announces Closing of Its Underwritten Public Offering of Common Stock

TherapeuticsMD received net proceeds from the offering of approximately $77.0 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by TherapeuticsMD. All of the shares in the offering were sold by TherapeuticsMD.read more

TherapeuticsMD stock slides 6% after SEC charges company with breaking disclosure rules

TherapeuticsMD Inc. shares slid about 6% Tuesday, after the Securities and Exchange Commission charged the company with breaching Regulation FD, or fair disclosure, for sharing material, non-public information with sell-side research analysts that was not disseminated more widely. The SEC found tha…

Thinking about buying stock in Apple, International Business Machines, Square Incorporated, TherapeuticsMD Inc or Yulong Eco-Materials?

NEW YORK, Oct. 29, 2018 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, IBM, SQ, TXMD, and YECO. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
Show more

TherapeuticsMD Blogs

TherapeuticsMD Provides COVID-19-Related Business Update

- Strong preliminary first quarter 2020 total net revenue projected to be more than $11 million – - vitaCare Prescription Services model allowing the Company to connect with more than 80% of patients - - Implementing staged contingency plan that can be adjusted as COVID-19 situation evolves - BOCA

Paul Bisaro

Paul Bisaro joseibrahim.de… Tue, 03/24/2020 - 11:50 Paul Bisaro Paul Bisaro is an accomplished global business leader with more than 25 years of generic and branded pharmaceutical experience, and an exceptional track record of driving company growth through operational execution an…

Gail Naughton

Gail Naughton joseibrahim.de… Tue, 03/24/2020 - 11:49 Gail Naughton Dr. Naughton is an accomplished life sciences executive and researcher. Dr. Naughton founded two regenerative medicine companies and is the holder of more than 105 U.S. and foreign patents. She served as the Dean o…

Chris Gish

Chris Gish joseibrahim.de… Tue, 03/24/2020 - 11:48 Chris Gish Senior Vice President, Sales Chris Gish is a seasoned biopharmaceutical sales executive with over 28 years of experience leading teams and driving results. His career includes leadership positions as…

Adam Miller

Adam Miller joseibrahim.de… Tue, 03/24/2020 - 11:47 Adam Miller Chief Information Officer & Chief Information Security Officer Adam Miller is Chief Information Officer & Chief Information Security Officer at TherapeuticsMD. Mr. Miller has more than 16 …

Jennifer Wilson

Jennifer Wilson joseibrahim.de… Tue, 03/24/2020 - 11:44 Jennifer Wilson Vice President, Business Development Jennifer Wilson began her healthcare career through investment banking, working in the Bank of America Merrill Lynch Healthcare Group. Her vast experienc…
Show more

TherapeuticsMD Frequently Asked Questions

  • When was TherapeuticsMD founded?

    TherapeuticsMD was founded in 2008.

  • Who are TherapeuticsMD key executives?

    TherapeuticsMD's key executives are Tommy G. Thompson, Robert G. Finizio and Dan Cartwright.

  • How many employees does TherapeuticsMD have?

    TherapeuticsMD has 348 employees.

  • What is TherapeuticsMD revenue?

    Latest TherapeuticsMD annual revenue is $49.6 m.

  • What is TherapeuticsMD revenue per employee?

    Latest TherapeuticsMD revenue per employee is $142.7 k.

  • Who are TherapeuticsMD competitors?

    Competitors of TherapeuticsMD include Tarsa Therapeutics, Ohana Biosciences and Laccure.

  • Where is TherapeuticsMD headquarters?

    TherapeuticsMD headquarters is located at 951 Yamato Rd #220, Boca Raton.

  • Where are TherapeuticsMD offices?

    TherapeuticsMD has an office in Boca Raton.

  • How many offices does TherapeuticsMD have?

    TherapeuticsMD has 1 office.